FSH
The pituitary glycoprotein hormone that drives gametogenesis in both sexes and forms the backbone of assisted-reproduction ovarian stimulation.
FSH (follicle-stimulating hormone) is an endogenous heterodimeric glycoprotein hormone secreted by pituitary gonadotrophs, built from a common alpha subunit shared with LH, TSH, and hCG plus an FSH-specific beta subunit that confers receptor specificity. It is the primary regulator of gametogenesis, acting on ovarian granulosa cells to drive follicular growth and estradiol synthesis and on testicular Sertoli cells to support spermatogenesis. FDA-approved recombinant preparations follitropin alfa (Gonal-f) and follitropin beta (Follistim) are prescription therapeutics used for ovulation induction, assisted reproductive technology, and hypogonadotropic hypogonadism in men, while research-grade recombinant FSH serves as a reproductive-biology and cell-culture tool.
Class
Endogenous heterodimeric glycoprotein hormone (gonadotropin)
Routes
Subcutaneous, Intramuscular
Category
Hormone & Reproductive
Researched benefits
What it's studied for
Ovarian stimulation for assisted reproduction
FSH drives controlled ovarian hyperstimulation in IVF and ICSI cycles by promoting multi-follicular growth. A Cochrane meta-analysis of 42 randomized trials established recombinant FSH as clinically equivalent to urinary gonadotropins for this indication, forming the evidence base for current ART practice.
Follicular development and estradiol synthesis
By binding granulosa-cell FSH receptors, FSH stimulates follicular maturation and upregulates aromatase to increase estradiol production, the core mechanism behind ovulation induction.
Spermatogenesis support
FSH binds Sertoli-cell receptors in the testis to promote germ-cell proliferation, sperm maturation, and inhibin B production, underlying its use in male hypogonadotropic hypogonadism and fertility support.
Fertility support in both sexes
As the primary regulator of gametogenesis, FSH is central to fertility interventions, with recombinant preparations used clinically to restore reproductive function when endogenous gonadotropin output is insufficient.
Mechanism
How it works
FSH is a heterodimeric glycoprotein composed of a common alpha subunit — shared with LH, TSH, and hCG — non-covalently associated with a unique FSH-specific beta subunit that determines receptor specificity. It is synthesized and secreted by pituitary gonadotrophs under hypothalamic and gonadal feedback control as part of the hypothalamic-pituitary-gonadal (HPG) axis.
FSH activates its cognate receptor (FSHR) through cAMP-mediated intracellular signaling. In the ovary, it acts on granulosa cells to drive follicular maturation and estradiol synthesis via upregulation of aromatase. In the testis, it acts on Sertoli cells to support spermatogenesis by promoting germ-cell proliferation and inhibin B production.
FSH secretion is governed by negative feedback from gonadal steroids and inhibins. As ovarian estrogen output declines at menopause, this feedback is lost and circulating FSH levels rise dramatically — a change increasingly studied for downstream effects beyond reproduction, including vascular endothelial function.
Evidence
Research & clinical studies (10)
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles
Across 42 randomized trials and 9,606 couples, recombinant FSH and urinary gonadotrophins showed no significant difference in live birth rate (OR 0.97, 95% CI 0.87-1.08), establishing clinical equivalence for ovarian stimulation in IVF/ICSI.
PMID 21328276The improvement of umbilical cord mesenchymal stem cells on the ovarian microenvironment: a systematic review and meta-analysis
In mouse models of premature ovarian failure, UCMSC transplantation lowered serum FSH while raising estradiol and anti-Müllerian hormone and increasing follicle counts across developmental stages.
PMID 42216054Recovery of gonadal axis in patients with prolactinomas
In cabergoline-treated prolactinoma patients, the HPG axis (including FSH) normalized over an average of 82 days, with recovery time influenced by baseline prolactin, gender, and age.
PMID 42214441Menopause and vascular endothelial health: Is it all about the oestrogen?
Rising FSH levels at menopause contribute to vascular endothelial dysfunction via endothelin-1 signaling, oxidative stress, and inflammation, beyond estrogen decline alone.
PMID 42218087Molecular analysis of FSHR rs6166 polymorphism and oxidative stress parameters in women with polycystic ovary syndrome
Examined the association between the FSH receptor rs6166 polymorphism and oxidative-stress parameters in women with PCOS.
PMID 42377768Revisiting ESR in PCOS: an easily obtainable link to immune and metabolic dysregulation
Explored erythrocyte sedimentation rate as an accessible marker linking immune and metabolic dysregulation in PCOS, a condition involving altered FSH signaling.
PMID 42374565Lycopene ameliorates acrylamide-induced reproductive toxicity through enhancement in testicular antioxidant status and upregulation of androgen receptor expression in male Wistar rats
Lycopene improved reproductive function in acrylamide-exposed rats by boosting testicular antioxidant defenses, upregulating androgen receptors, and restoring FSH balance and sperm quality.
PMID 42216064Effect of laparoscopic ovum pick-up on ovine in vitro oocyte maturation and somatic cell nuclear transfer embryo development
Laparoscopic ovum pick-up yielded higher-quality sheep oocytes with improved in vitro maturation and greater cloning efficiency than slaughterhouse-derived oocytes.
PMID 42214813Functional Landscape of Zebrafish Gonadotropins and Receptors: A Comprehensive Genetic Analysis
Comprehensive genetic analysis mapped the functional roles of gonadotropins and their receptors, including FSH signaling, in zebrafish reproduction.
PMID 42376857Association between sex hormone levels and high-sensitivity C-reactive protein in older adults aged 65 years and above in 18 longevity areas in China
Investigated associations between sex hormone levels, including FSH, and high-sensitivity C-reactive protein in older Chinese adults across longevity regions.
PMID 42373476Safety
Side effects & considerations
Contraindications & cautions
- Active or history of cancer
- Thyroid condition
- Cardiovascular condition
- Pregnancy or nursing
FSH carries a moderate risk profile in research and clinical contexts. Reported contraindications include active cancer history, thyroid conditions, cardiovascular conditions, and pregnancy or nursing. Use is prescription-only and should be supervised by a qualified clinician; review the full contraindication list before any use.
FAQ
FSH — common questions
What is FSH?
FSH (follicle-stimulating hormone) is an endogenous heterodimeric glycoprotein hormone secreted by pituitary gonadotrophs. It comprises a common alpha subunit shared with LH, TSH, and hCG plus an FSH-specific beta subunit, and it is the primary regulator of gametogenesis, acting on ovarian granulosa cells and testicular Sertoli cells.
What is FSH primarily studied for?
Its main research and clinical areas are spermatogenesis, fertility support, follicular development, ovarian stimulation, and regulation of the hypothalamic-pituitary-gonadal (HPG) axis.
How does FSH work?
FSH activates its receptor (FSHR) via cAMP-mediated signaling. In women it drives follicular maturation and estradiol synthesis through aromatase upregulation; in men it supports spermatogenesis by promoting Sertoli-cell function and germ-cell proliferation.
Is recombinant FSH as effective as urinary gonadotropins?
A Cochrane meta-analysis of 42 randomized trials (9,606 couples) found no significant difference in live birth rate between recombinant FSH and urinary gonadotrophins for ovarian stimulation in IVF/ICSI, establishing clinical equivalence and letting selection be based on availability and cost.
Why do FSH levels rise at menopause?
As ovarian estrogen production declines, the negative feedback that normally suppresses FSH is lost, so circulating FSH rises dramatically. Emerging research links this rise to vascular endothelial effects beyond estrogen loss.
What are the side effects and contraindications of FSH?
FSH has a moderate risk profile. Reported contraindications include active cancer history, thyroid conditions, cardiovascular conditions, and pregnancy or nursing. It is prescription-only and should be used under clinician supervision.
Is FSH legal and FDA-approved?
Yes. Recombinant FSH preparations follitropin alfa (Gonal-f) and follitropin beta (Follistim) are FDA-approved prescription medications for ovulation induction, assisted reproduction, and male hypogonadotropic hypogonadism.
